Associated virus-bacterial vaccine based on seasonal LAIV and S. pneumoniae chimeric peptide provide protection against post-influenza pneumococcal infection in mouse model
Severe influenza complications are often caused by Streptococcus pneumoniae infection, which presents the most common cause of community-acquired pneumonia. We evaluated in a mouse model an associated virus-bacterial vaccine based on seasonal live influenza vaccines (LAIV) and S. pneumoniae chimeric...
Main Authors: | Yulia Desheva, Galina Leontieva, Tatiana Kramskaya, Igor Losev, Nadezhda Petkova, Andrey Rekstin, Alexander Suvorov |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Virulence |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/21505594.2022.2049496 |
Similar Items
-
Live Influenza Vaccine Provides Early Protection against Homologous and Heterologous Influenza and May Prevent Post-Influenza Pneumococcal Infections in Mice
by: Yulia Desheva, et al.
Published: (2022-06-01) -
Developing a Live Probiotic Vaccine Based on the <i>Enterococcus faecium</i> L3 Strain Expressing Influenza Neuraminidase
by: Yulia Desheva, et al.
Published: (2021-11-01) -
Immune predisposition drives susceptibility to pneumococcal pneumonia after mild influenza A virus infection in mice
by: Sunil Palani, et al.
Published: (2023-09-01) -
Vaccination for the control of childhood bacterial pneumonia - Haemophilus influenzae type b and pneumococcal vaccines
by: Diana C Otczyk, et al.
Published: (2013-01-01) -
Could Trivalent LAIV Protect Against Both Genetic Lineages of Influenza B Virus?
by: Irina Kiseleva, et al.
Published: (2019-06-01)